ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

BCTX BriaCell Therapeutics Corporation

2,26
0,02 (0,89%)
04 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
BriaCell Therapeutics Corporation BCTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,02 0,89% 2,26 01:00:08
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,25 2,23 2,34 2,26 2,24
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202409:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
10/04/202409:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
09/04/202409:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
07/03/202410:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
06/03/202410:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
27/02/202410:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
07/02/202410:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
06/02/202410:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
31/01/202400:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
04/01/202410:45GLOBEBriaCell Images Confirm Robust Anti-Tumor Activity in..
28/12/202310:55GLOBEBriaCell Reports 71% Central Nervous System Response Rate in..
20/12/202310:40GLOBEBriaCell Reports Unprecedented Preliminary Survival and..
06/12/202311:31GLOBEBriaCell Highlights Outstanding Topline Survival and..
06/12/202311:00GLOBEBriaCell 2023 SABCS Posters Confirm Activation of..
30/11/202309:00GLOBEBriaCell Records New Responder with Remarkable Improvement..
03/11/202309:31GLOBEBriaCell Reports Unprecedented Anti-Tumor Activity of its..
25/10/202310:15GLOBEBriaCell Forms Medical Advisory Board of Distinguished..
20/10/202310:15GLOBEOctober is Breast Cancer Awareness Month – BriaCell is..
18/10/202310:00GLOBEBriaCell Announces Presentations at the 2023 Society for the..
11/10/202310:10GLOBEBriaCell To Host Virtual Key Opinion Leader Event on..
04/10/202310:00GLOBEBriaCell Partners with New York Cancer & Blood Specialists..
03/10/202310:00GLOBEBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in..
08/09/202308:00GLOBEBriaCell Reports Benchmark-Beating Patient Survival and..
31/08/202312:54GLOBEBriaCell Therapeutics Corp. Announces Closing of Plan of..
31/08/202309:21GLOBEBriaCell Accepts Letter of Intent from Weill Cornell..
25/08/202315:33GLOBEBriaCell Receives Court Approval for the Share Arrangement..
18/08/202313:21GLOBEBriaCell Therapeutics Corp. Announces Voting Results From..
16/08/202309:36GLOBEBriaCell Awarded National Cancer Institute Grant to Advance..
27/06/202310:37APSNews Brief: BriaCell Therapeutics Corp.
27/06/202309:05GLOBEFDA Approves BriaCell’s Pivotal Registrational Study Design..
25/05/202310:00GLOBEBriaCell Enters Definitive Arrangement Agreement for the..
19/05/202312:38GLOBEBriaCell Closes $4 Million Strategic Investment by Prevail..
15/05/202309:00GLOBEBriaCell Announces $4 Million Strategic Investment and..

Seu Histórico Recente

Delayed Upgrade Clock